Hemispherx Biopharma buy melinda
Start price
18.08.10
/
50%
€231.79
Target price
18.02.11
€462.00
Performance (%)
-20.05%
End price
18.02.11
€185.33
Summary
This prediction ended on 18.02.11 with a price of €185.33. The prediction for Hemispherx Biopharma disappointed with a performance of -20.05%. melinda has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Hemispherx Biopharma | - | - | - | - |
| iShares Core DAX® | 0.734% | -0.964% | 17.910% | 65.510% |
| iShares Nasdaq 100 | -2.686% | -2.409% | 4.267% | 95.368% |
| iShares Nikkei 225® | -2.261% | -4.038% | 10.420% | 42.232% |
| iShares S&P 500 | -1.346% | -1.510% | 1.615% | 59.132% |
Comments by melinda for this prediction
In the thread Hemispherx Biopharma diskutieren
Biopharma-
hemispherix Biopharma verkündete seine Schlacht gewonnen sechs Jahren südafrikanischen Investoren, dass sie gewonnen haben
(Laufzeit überschritten)
Stopped prediction by melinda for Hemispherx Biopharma
Hemispherx Biopharma
Start price
Target price
Perf. (%)
€20.02
18.05.17
18.05.17
€26.40
26.05.17
26.05.17
5.27%
26.05.17
26.05.17
